MD3425G2 - Method of prophylaxis and treatment of nervous system pathologies to children - Google Patents
Method of prophylaxis and treatment of nervous system pathologies to childrenInfo
- Publication number
- MD3425G2 MD3425G2 MDA20070142A MD20070142A MD3425G2 MD 3425 G2 MD3425 G2 MD 3425G2 MD A20070142 A MDA20070142 A MD A20070142A MD 20070142 A MD20070142 A MD 20070142A MD 3425 G2 MD3425 G2 MD 3425G2
- Authority
- MD
- Moldova
- Prior art keywords
- months
- nervous system
- treatment
- children
- prophylaxis
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The invention refers to medicine, namely to the pediatric neurology and obstetrics and may be used for early prophylaxis and treatment of nervous system diseases to children, which are caused by the intrauterine immaturity of nervous system.Summary of the method consists in that it is daily administered per os the preparation Maturinol after meals at the age of 1 month - 30 drops, at the age of 2 months - 1,5 ml, at 3 months - 3 ml, at 4…6 months - 6…12 ml, at 7 and more months for 1 ml/kg of weight, the dose being divided into 2…3 intakes a day, concomitantly it is administered lecitine for 200…300 mg 2…3 times a day and vegetable oil for 0,5…2 ml 2…3 times a day during meals, the treatment cure being of 2…12 months.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20070142A MD3425G2 (en) | 2007-05-17 | 2007-05-17 | Method of prophylaxis and treatment of nervous system pathologies to children |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20070142A MD3425G2 (en) | 2007-05-17 | 2007-05-17 | Method of prophylaxis and treatment of nervous system pathologies to children |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3425F1 MD3425F1 (en) | 2007-11-30 |
MD3425G2 true MD3425G2 (en) | 2008-06-30 |
Family
ID=38819352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20070142A MD3425G2 (en) | 2007-05-17 | 2007-05-17 | Method of prophylaxis and treatment of nervous system pathologies to children |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3425G2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD966Z (en) * | 2015-01-29 | 2016-06-30 | Штефан ГАЦКАН | Method for predicting the risk of development of congenital pathology of the central nervous system in the fetus |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1050G2 (en) * | 1998-01-22 | 1999-05-31 | Svetlana Hadjiu | Method for treatment of the young children perinatal hypoxic ischemic encefalopathy |
MD2324G2 (en) * | 2003-07-25 | 2004-07-31 | Ион ИЛИЧУК | Metabolism regulating medicament |
MD2903G2 (en) * | 2005-04-12 | 2006-06-30 | Ион ИЛИЧУК | Medicinal remedy for treatment of central and peripheral nervous system to children |
MD2904G2 (en) * | 2005-04-12 | 2006-06-30 | Каролина ВАРВАРЮК | Use of Gerovital H3 preparation for treatment of central nervous system affections to children |
-
2007
- 2007-05-17 MD MDA20070142A patent/MD3425G2/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1050G2 (en) * | 1998-01-22 | 1999-05-31 | Svetlana Hadjiu | Method for treatment of the young children perinatal hypoxic ischemic encefalopathy |
MD2324G2 (en) * | 2003-07-25 | 2004-07-31 | Ион ИЛИЧУК | Metabolism regulating medicament |
MD2903G2 (en) * | 2005-04-12 | 2006-06-30 | Ион ИЛИЧУК | Medicinal remedy for treatment of central and peripheral nervous system to children |
MD2904G2 (en) * | 2005-04-12 | 2006-06-30 | Каролина ВАРВАРЮК | Use of Gerovital H3 preparation for treatment of central nervous system affections to children |
Non-Patent Citations (1)
Title |
---|
Aicardi J. Disease of the nervous system in childhood. Oxford, N. I. Mackeith Press, 1992, 1363 p. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD966Z (en) * | 2015-01-29 | 2016-06-30 | Штефан ГАЦКАН | Method for predicting the risk of development of congenital pathology of the central nervous system in the fetus |
Also Published As
Publication number | Publication date |
---|---|
MD3425F1 (en) | 2007-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6446552B2 (en) | Compositions used for weight and body fat reduction and their pharmaceuticals and uses | |
AR124500A2 (en) | INCREASED BIOAVAILABILITY OF THE DRUG IN NALTREXONE THERAPY | |
WO2014205229A8 (en) | Use of high dose pridopidine for treating huntington's disease | |
WO2007136518A3 (en) | Treatment of autoimmune disorders | |
BR112017009678A2 (en) | optimized composition of fatty acid nutrients and method of preparation thereof | |
RU2018111327A (en) | METHOD FOR INHIBITING SUCTION AND / OR INCREASING LIPID WITHDRAWAL USING D-PSYCOSIS | |
TW200803865A (en) | Composition containing riboflavin and sesamins | |
WO2012142615A3 (en) | Auranofin and auranofin analogs useful to treat proliferative disease and disorders | |
Almasi | Flaxseed prevents interferon-alpha induced depressive behavior in mice: the α-linolenic acid is essential | |
UA91028C2 (en) | Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress | |
BR112016017765A8 (en) | composition comprising cinnamaldehyde and zinc, their use, and method for producing a weight loss food product | |
MD3425G2 (en) | Method of prophylaxis and treatment of nervous system pathologies to children | |
WO2016008642A3 (en) | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions | |
JP6368368B2 (en) | Compositions and methods using p-anisaldehyde | |
JP6360172B2 (en) | Compositions and methods using tiglinaldehyde | |
TW201613606A (en) | Therapeutic drug for chronic renal failure | |
US20240050510A1 (en) | Combination therapy comprising uncaria for treating anxiety and depression | |
WO2015178492A1 (en) | Anti-allergy agent, agent for alleviating diarrhea caused by allergies, and medical composition | |
JP2016525133A (en) | Compositions and methods using cuminaldehyde | |
EP2983499B1 (en) | Food supplement compensating unfavourable vaccination effects | |
AR076016A1 (en) | DOMPERIDONE AT A LOW DAILY DOSE FOR USE IN THE TREATMENT OR PREVENTION OF AN ILLNESS ASSOCIATED WITH AN ALTERATION OF THE IMMUNE RESPONSE | |
Dasari | Ataxia due to phenytoin toxicity: case report | |
MY159675A (en) | Clerodane derivatives for modulation of leukotriene receptor activity and related diseases | |
Pasha | Various toxicities: 3 case reports | |
Alarcon-Payer | Sodium oxybate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |